The FDA approved “the Quad”- a four-medication-in-one-pill treatment for controlling HIV. Two of the medications comprising Stribild, tenofovir and emtricitabine, have been previously combined and sold under the brand name Truvada (itself approved a few weeks ago as a preventative or prophylactic for HIV, see related articles below).
Two of the medications are new, and – as a condition of approval- will require greater testing in women and children, as well as studying possibilities and occasions of resistance.
This is good news.
Simplifying regimens is a helpful strategy in helping keep HIV-infected persons faithful to their medication schedules, a key in effectively treating HIV. Cost is yet to be determined- and most HIV regimens cost in excess of $18,000.00 a year (mine cost $24k).
Still no picnic- but good news for those who need a simpler med schedule.
- FDA Approves Gilead’s HIV Quad Pill Stribild – Wall Street Journal (drugstoresource.wordpress.com)
- FDA’s Approval of Stribild Will Simplify Treatment for HIV Patients (guardianlv.com)
- Truvada Approved For HIV Prevention (dgsmith.org)